Skip to main content

Published locations for ASH: Idelalisib plus standard therapy boosts survival in relapsed CLL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ASH: Idelalisib plus standard therapy boosts survival in relapsed CLL

User login

  • Reset your password
  • /content/ash-idelalisib-plus-standard-therapy-boosts-survival-relapsed-cll
  • /hematologynews/article/105045/cll/ash-idelalisib-plus-standard-therapy-boosts-survival-relapsed-cll
  • /oncologypractice/article/105045/cll/ash-idelalisib-plus-standard-therapy-boosts-survival-relapsed
  • /hematology-oncology/article/105045/cll/ash-idelalisib-plus-standard-therapy-boosts-survival-relapsed
  • /b-cell-lymphoma-icymi/article/105045/cll/ash-idelalisib-plus-standard-therapy-boosts-survival